We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Silencing Protein Found to Be Enzyme Modifier

By Biotechdaily staff writers
Posted on 24 Jan 2003
Researchers have found that the Sir2 protein, known to be required for gene silencing, modifies the enzyme acetyl-CoA synthetase that may be related to the extended lifespan in many organisms resulting when calories are restricted. More...
The finding was reported in the December 20, 2002, issue of Science.

Silencing is a form of transcriptional repression that renders large chromatin domains inaccessible to the transcription machinery. Silenced domains are refractile to recombination, replicate late in S phase and are inaccessible to some but not all molecular probes. In Saccharomyces cerevisiae (budding yeast) silencing occurs at three loci: the cryptic mating type loci, HMR and HML; the telomeres (referred as telomeric position effect, TPE); and at the rDNA locus (called RPE).

SIR2 distinguishes itself from the other SIR genes as it is essential for the three types of silencing and is conserved from bacteria to man. Four paralogs of Sir2p exist in budding yeast, the Hst1-4 proteins, and more than one Sir2 ortholog is found in all other species examined. They are called sirtuins. Recently, numerous studies have demonstrated that Sir2p is an in vitro NAD-dependent deacetylase and that this enzymatic activity appears to correlate with repression at the HM, telomeres, and rDNA loci. However, the physiologic Sir2p substrates have not yet been identified.

Working with a mutated strain of bacteria lacking sirtuins, investigators from Johns Hopkins University (Baltimore, MD, USA; www.jhu.edu) and the University of Wisconsin (Madison, USA; www.wisc.edu) discovered that Sir2 was a crucial modifier of the enzyme acetyl-CoA synthetase, which converts acetate into acetyl-CoA in a two-step process. Acetyl-CoA then can directly fuel the citric acid cycle, the central energy-producing step in cellular respiration.

"This is a completely new target for the sirtuin protein,” explained investigator Dr. Jeff Boeke, professor of molecular biology and genetics at Johns Hopkins' Institute for Basic Biomedical Sciences. "Converting acetate is not the cell's only way of making acetyl-CoA, but when acetate is the major energy source, it is crucial. Now we have to check for this role in other organisms.”




Related Links:
John Hopkins University
University of Wisconsin

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.